The FDA’s approval of Ozempic to battle chronic kidney disease “allows us to more broadly address conditions within cardiovascular-kidney-metabolic syndrome, which affects millions of ...
Controversial Health and Human Services nominee Robert F. Kennedy Jr. was back on Capitol Hill Thursday morning to answer ...